Seres Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Seres Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Seres Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Seres Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $528k | 60k | 8.87 |
| 2025-12-31 | $1.1M | 74k | 14.88 |
| 2025-09-30 | $1.6M | 85k | 19.24 |
| 2025-06-30 | $119k | 11k | 11.11 |